Tenet Healthcare Corp (NYSE: THC) has reported earnings for its fourth fiscal quarter (ending December 31) of $3.34 versus $2.42 for the same period a year ago — an increase of 38%. This result exceeded the consensus estimate of $2.83 by $0.51. For the latest four quarters through December 31, E.P.S. were $33.02 compared to $6.01 a year ago — an increase of 449%.
Recent Price Action
Tenet Healthcare Corp (NYSE: THC) stock closed at $126.19 on 2/12/25 after a large decline of -9.1%. Moreover, trading volume in this decline was exceptionally high at 354% of normal. The stock has declined -12.2% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Tenet Healthcare has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Tenet Healthcare has a neutral Power Rating of 57 but a good Appreciation Score of 73, with the Positive Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment